Gene name and description | Signal intensity | Accession no. | |||||
---|---|---|---|---|---|---|---|
CA | CCS | BA | BCS | LYA | LYCS | ||
Xenobiotic/drug metabolism | |||||||
Cytochrome P450, 1a1; Cyp1a1 | 81 ± 16 | 4,947 ± 730*** | 126 ± 15 | 3,985 ± 168*** | 157 ± 7 | 4,652 ± 326*** | NM_009992 |
Cytochrome P450, f1b1; Cyp1b1 | 223 ± 61 | 2,150 ± 541** | 113 ± 7 | 1,657 ± 110*** | 165 ± 15 | 1,760 ± 1023*** | BI251808 |
Cytochrome P450, family 2, a4///a5; Cyp2a4///Cyp2a5 | 938 ± 336 | 2,042 ± 477** | 942 ± 69 | 2,071 ± 127*** | 630 ± 113 | 2,195 ± 273** | NM_007812 |
Aldehyde dehydrogenase family 3, a1; Aldh3a1 | 378 ± 91 | 1,072 ± 262** | 171 ± 12 | 836 ± 43*** | 312 ± 24 | 1,296 ± 61*** | NM_007436 |
Alcohol dehydrogenase 7 (class IV); Adh7 | 269 ± 73 | 814 ± 182** | 151 ± 13 | 718 ± 33*** | 201 ± 18 | 859 ± 109** | NM_009626 |
Aldo-keto reductase family 1, member B8; Akr1b8 | 623 ± 175 | 945 ± 242# | 343 ± 30 | 759 ± 36*** | 449 ± 3 | 1,095 ± 70*** | NM_008012 |
Carboxylesterase 1; Ces1 | 93 ± 29 | 511 ± 146** | 68 ± 8 | 420 ± 35*** | 88 ± 7 | 575 ± 42*** | NM_021456 |
NAD(P)H dehydrogenase, quinone 1; Nqo1 | 119 ± 23 | 403 ± 64** | 85 ± 3 | 366 ± 8*** | 124 ± 8 | 534 ± 10*** | AV158882 |
Glutathione S-transferase, alpha 2; Gsta2 | 242 ± 60 | 569 ± 159# | 148 ± 13 | 485 ± 11*** | 245 ± 19 | 654 ± 39*** | NM_008182 |
Glutathione S-transferase, alpha 3; Gsta3 | 349 ± 91 | 770 ± 139 | 294 ± 21 | 615 ± 58** | 364 ± 16 | 771 ± 42*** | AI172943 |
Carbonyl reductase 3; Cbr3 | 604 ± 148 | 1,398 ± 304* | 284 ± 87 | 1,174 ± 29*** | 469 ± 23 | 1,472 ± 67*** | AK003232 |
Glutathione reductase 1; Gsr | 277 ± 30 | 348 ± 29# | 492 ± 48 | 443 ± 18# | 356 ± 15 | 1,007 ± 176** | AK019177 |
Glutamate-cysteine ligase, modifier subunit; Gclm | 402 ± 75 | 887 ± 173** | 320 ± 14 | 706 ± 32*** | 326 ± 35 | 1,105 ± 29*** | NM_008129 |
Flavin containing monooxygenase 2; Fmo2 | 1,814 ± 583 | 2,284 ± 629# | 1,203 ± 188 | 1,688 ± 156# | 876 ± 115 | 2,056 ± 127*** | NM_018881 |
Inflammatory-immune response | |||||||
Paired-Ig-like receptor A1; Pira1 | 138 ± 38 | 80 ± 29# | 139 ± 20 | 69 ± 4** | 108 ± 5 | 310 ± 64** | NM_011087 |
Paired immunoglobin-like type 2 receptor alpha; Pilra | 139 ± 42 | 104 ± 48# | 130 ± 10 | 73 ± 7** | 89 ± 2 | 262 ± 62* | BB775785 |
Paired immunoglobin-like type 2 receptor beta; Pilrb | 248 ± 47 | 166 ± 46# | 254 ± 34 | 92 ± 3** | 186 ± 10 | 563 ± 131* | NM_133209 |
EGF-like module containing, mucin-like, r4; Emr4 | 285 ± 99 | 170 ± 117# | 179 ± 13 | 45 ± 3*** | 191 ± 15 | 162 ± 22# | AF396935 |
Killer cell lectin-like receptor, a3; Klra3 | 595 ± 188 | 307 ± 103# | 299 ± 21 | 131 ± 16*** | 401 ± 42 | 365 ± 48# | U49865 |
Fibrinogen-like protein 2; Fgl2 | 269 ± 90 | 165 ± 58# | 240 ± 43 | 120 ± 9** | 171 ± 10 | 377 ± 63** | BF136544 |
Protein tyrosine phosphatase, receptor type, C; Ptprc | 3,348 ± 987 | 1,540 ± 533# | 2,266 ± 156 | 960 ± 50*** | 2,287 ± 53 | 3,103 ± 391# | NM_011210 |
Lymphocyte antigen 86; Ly86 | 825 ± 272 | 304 ± 86# | 433 ± 45 | 186 ± 14** | 599 ± 70 | 443 ± 9** | NM_010745 |
Leukocyte specific transcript 1; Lst1 | 359 ± 101 | 127 ± 46* | 280 ± 54 | 49 ± 6** | 215 ± 20 | 460 ± 84* | U72644 |
Coronin, actin binding protein 1A; Coro1a | 1,153 ± 319 | 574 ± 180# | 821 ± 91 | 416 ± 37** | 910 ± 113 | 1,415 ± 231# | BB740218 |
GLI pathogenesis-related 2; Glipr2 | 146 ± 44 | 65 ± 24# | 148 ± 15 | 62 ± 2** | 132 ± 3 | 276 ± 68# | BM208214 |
Matrix metalloproteinase 8; Mmp8 | 145 ± 33 | 86 ± 11# | 272 ± 83 | 78 ± 11** | 69 ± 6 | 2,465 ± 670** | NM_008611 |
Matrix metalloproteinase 9; Mmp9 | 185 ± 33 | 84 ± 18** | 222 ± 66 | 68 ± 5** | 92 ± 3 | 830 ± 237** | NM_013599 |
Interleukin 1 beta; Il1b | 534 ± 171 | 141 ± 39* | 763 ± 243 | 102 ± 12** | 179 ± 37 | 1,759 ± 464** | BC011437 |
Interleukin 8 receptor, beta; Il8rb | 83 ± 29 | 19 ± 5* | 103 ± 37 | 14 ± 7** | 20 ± 6 | 256 ± 41** | NM_009909 |
Phospholipase A2, group VII; Pla2g7 | 229 ± 66 | 129 ± 55# | 350 ± 77 | 129 ± 8** | 124 ± 14 | 975 ± 244** | AK005158 |
Colony stimulating factor 3 receptor (granulocyte); Csf3r | 417 ± 90 | 163 ± 45** | 619 ± 200 | 133 ± 23** | 175 ± 30 | 1,322 ± 279** | NM_007782 |
Formyl peptide receptor, related sequence 2; Fpr-rs2 | 475 ± 110 | 399 ± 165# | 383 ± 44 | 217 ± 7** | 273 ± 14 | 1,256 ± 282** | NM_008039 |
Formyl peptide receptor 1; Fpr1 | 238 ± 63 | 154 ± 41# | 224 ± 11 | 126 ± 15** | 133 ± 19 | 572 ± 140** | NM_013521 |
Secretory leukocyte protease inhibitor; Slpi | 721 ± 115 | 683 ± 193# | 735 ± 96 | 655 ± 89# | 461 ± 44 | 1,817 ± 331** | NM_011414 |
Synuclein, alpha; Snca | 393 ± 87 | 601 ± 109# | 292 ± 17 | 388 ± 31** | 398 ± 25 | 954 ± 109** | NM_009221 |
Fc receptor, IgG, low affinity III; Fcgr3 | 287 ± 57 | 278 ± 65# | 300 ± 35 | 201 ± 26* | 213 ± 21 | 730 ± 129** | NM_010188 |
Triggering receptor expressed on myeloid cells 3; Trem3 | 131 ± 32 | 89 ± 31# | 108 ± 8 | 41 ± 2*** | 76 ± 4 | 315 ± 64** | NM_021407 |
Cadherin 2; Cdh2 | 154 ± 39 | 101 ± 35# | 128 ± 15 | 95 ± 8# | 223 ± 12 | 166 ± 16** | BC022107 |
Glycoprotein 49 A; Gp49a///Lilrb4 | 945 ± 247 | 580 ± 157# | 945 ± 193 | 413 ± 15** | 580 ± 12 | 1,564 ± 263** | U05264 |
C-type lectin domain family 4, member d; Clec4d | 214 ± 42 | 121 ± 38# | 413 ± 128 | 103 ± 12** | 122 ± 12 | 1,226 ± 341** | NM_010819 |
C-type lectin domain family 4, member e; Clec4e | 59 ± 19 | 44 ± 19# | 63 ± 18 | 22 ± 2* | 26 ± 4 | 226 ± 72* | NM_019948 |
Metabolism and ion-channels | |||||||
Argininosuccinate synthetase 1; Ass1 | 183 ± 42 | 253 ± 50# | 209 ± 78 | 174 ± 10# | 145 ± 8 | 186 ± 23# | NM_007494 |
Histidine decarboxylase; Hdc | 1,075 ± 269 | 368 ± 127* | 624 ± 48 | 304 ± 14*** | 844 ± 97 | 862 ± 139# | BG072171 |
Ubiquitin specific protease 2; Usp2 | 111 ± 33 | 214 ± 57# | 64 ± 2 | 162 ± 8*** | 95 ± 6 | 153 ± 7** | AI553394 |
Lysyl oxidase-like 1; Loxl1 | 1,666 ± 319 | 642 ± 181** | 1,000 ± 74 | 454 ± 48*** | 1573 ± 55 | 874 ± 141** | AF357006 |
Sodium channel, voltage-gated, 3b; Scn3b | 1,220 ± 201 | 681 ± 170# | 753 ± 55 | 348 ± 28*** | 1,221 ± 139 | 910 ± 136# | BE951842 |
Stearoyl-Coenzyme A desaturase 1; Scd1 | 917 ± 265 | 617 ± 124# | 801 ± 82 | 341 ± 59** | 1,192 ± 292 | 937 ± 195# | NM_009127 |
Serine (or cysteine) proteinase inhibitor, clade H1; Serpinh1 | 1,377 ± 40 | 802 ± 74*** | 1,574 ± 153 | 799 ± 76** | 1,915 ± 230 | 1,253 ± 188* | BB329489 |
Solute carrier family 7a10; Slc7a10 | 415 ± 46 | 270 ± 42* | 381 ± 12 | 214 ± 18*** | 533 ± 35 | 414 ± 57# | NM_017394 |
Solute carrier family 28a2; Slc28a2 | 146 ± 41 | 51 ± 13* | 128 ± 21 | 37 ± 6** | 125 ± 19 | 274 ± 66# | NM_021520 |
Topoisomerase (DNA) II alpha; Top2a | 183 ± 43 | 117 ± 30# | 127 ± 8 | 74 ± 8** | 62 ± 32 | 165 ± 20# | BM211413 |
Solute carrier family 40 (iron-regulated transporter)1; Slc40a1 | 387 ± 103 | 310 ± 77# | 334 ± 88 | 284 ± 28# | 284 ± 16 | 1,006 ± 147** | AF226613 |
Solute carrier family 38, member 5; Slc38a5 | 462 ± 85 | 231 ± 55** | 285 ± 27 | 211 ± 26# | 472 ± 9 | 298 ± 44** | BG066984 |
Guanine deaminase; Gda | 92 ± 22 | 73 ± 23# | 105 ± 19 | 52 ± 4** | 61 ± 5 | 308 ± 65** | NM_010266 |
Peptidyl arginine deiminase, type IV; Padi4 | 43 ± 10 | 20 ± 4# | 64 ± 15 | 17 ± 3** | 40 ± 4 | 249 ± 78* | NM_011061 |
Arachidonate 5-lipoxygenase activating protein; Alox5ap | 1,428 ± 246 | 1,050 ± 171# | 1,226 ± 185 | 867 ± 27# | 1,212 ± 75 | 2,748 ± 434** | BC026209 |
Amiloride binding protein 1; Abp1 | 355 ± 100 | 116 ± 43* | 155 ± 24 | 106 ± 8# | 230 ± 35 | 94 ± 17** | BC021880 |
Apoptosis | |||||||
Granzyme A; Gzma | 1,176 ± 392 | 531 ± 194# | 633 ± 44 | 219 ± 20*** | 688 ± 92 | 801 ± 85# | NM_010370 |
Insulin-like growth factor binding protein 3; Igfbp3 | 757 ± 122 | 350 ± 95** | 468 ± 38 | 357 ± 21** | 794 ± 23 | 345 ± 37*** | AV175389 |
Chloride channel calcium activated 1; Clca1 | 122 ± 24 | 147 ± 39# | 127 ± 22 | 181 ± 9* | 103 ± 4 | 261 ± 44** | AF047838 |
Receptor | |||||||
Angiotensin receptor-like 1; Agtrl1 | 251 ± 36 | 138 ± 17** | 169 ± 13 | 135 ± 19# | 2,934 ± 210 | 1,485 ± 453** | BB533323 |
Membrane-spanning 4-domains, a1; Ms4a1 | 259 ± 86 | 95 ± 31# | 120 ± 16 | 55 ± 5** | 201 ± 17 | 159 ± 30# | BB236617 |
Membrane-spanning 4-domains, a4b; Ms4a4b | 655 ± 197 | 312 ± 126# | 342 ± 35 | 145 ± 11** | 481 ± 44 | 422 ± 62# | BB199001 |
Membrane-spanning 4-domains, a4c; Ms4a4c | 408 ± 145 | 78 ± 33* | 216 ± 51 | 38 ± 2** | 236 ± 47 | 295 ± 62# | NM_029499 |
Membrane-spanning 4-domains, a6b; Ms4a6b | 1,031 ± 305 | 549 ± 162# | 703 ± 56 | 332 ± 24*** | 701 ± 43 | 805 ± 98# | NM_027209 |
Cell proliferation | |||||||
tetraspanin 4; Tspan4 | 376 ± 64 | 1,387 ± 243** | 532 ± 32 | 1,145 ± 99*** | 622 ± 13 | 1,180 ± 160** | NM_053082 |
Placenta-specific 8; Plac8 | 2,254 ± 538 | 913 ± 292* | 1,601 ± 144 | 485 ± 41*** | 1,415 ± 114 | 2,077 ± 200** | AF263458 |
Unknown function | |||||||
Macrophage activation 2 like; Mpa2 l | 154 ± 33 | 68 ± 20* | 82 ± 10 | 41 ± 3** | 130 ± 10 | 117 ± 15# | BM241485 |
Histone 1, H2ad; Hist1h2ad | 319 ± 111 | 230 ± 93# | 231 ± 45 | 132 ± 7* | 112 ± 17 | 351 ± 30** | W91024 |
Apoptosis | |||||||
Granzyme A; Gzma | 1,176 ± 392 | 531 ± 194# | 633 ± 44 | 219 ± 20*** | 688 ± 92 | 801 ± 85# | NM_010370 |
Insulin-like growth factor binding protein 3; Igfbp3 | 757 ± 122 | 350 ± 95** | 468 ± 38 | 357 ± 21** | 794 ± 23 | 345 ± 37*** | AV175389 |
Chloride channel calcium activated 1; Clca1 | 122 ± 24 | 147 ± 39# | 127 ± 22 | 181 ± 9* | 103 ± 4 | 261 ± 44** | AF047838 |
Receptor | |||||||
Angiotensin receptor-like 1; Agtrl1 | 251 ± 36 | 138 ± 17** | 169 ± 13 | 135 ± 19# | 2,934 ± 210 | 1,485 ± 453** | BB533323 |
Membrane-spanning 4-domains, a1; Ms4a1 | 259 ± 86 | 95 ± 31# | 120 ± 16 | 55 ± 5** | 201 ± 17 | 159 ± 30# | BB236617 |
Membrane-spanning 4-domains, a4b; Ms4a4b | 655 ± 197 | 312 ± 126# | 342 ± 35 | 145 ± 11** | 481 ± 44 | 422 ± 62# | BB199001 |
Membrane-spanning 4-domains, a4c; Ms4a4c | 408 ± 145 | 78 ± 33* | 216 ± 51 | 38 ± 2** | 236 ± 47 | 295 ± 62# | NM_029499 |
Membrane-spanning 4-domains, a6b; Ms4a6b | 1,031 ± 305 | 549 ± 162# | 703 ± 56 | 332 ± 24*** | 701 ± 43 | 805 ± 98# | NM_027209 |
Cell proliferation | |||||||
Tetraspanin 4; Tspan4 | 376 ± 64 | 1,387 ± 243** | 532 ± 32 | 1,145 ± 99*** | 622 ± 13 | 1,180 ± 160** | NM_053082 |
Placenta-specific 8; Plac8 | 2,254 ± 538 | 913 ± 292* | 1,601 ± 144 | 485 ± 41*** | 1,415 ± 114 | 2,077 ± 200** | AF263458 |
Unknown function | |||||||
Macrophage activation 2 like; Mpa2 l | 154 ± 33 | 68 ± 20* | 82 ± 10 | 41 ± 3** | 130 ± 10 | 117 ± 15# | BM241485 |
Histone 1, H2ad; Hist1h2ad | 319 ± 111 | 230 ± 93# | 231 ± 45 | 132 ± 7* | 112 ± 17 | 351 ± 30** | W91024 |
Transcription and growth factors | |||||||
Period homolog 2 (Drosophila); Per2 | 175 ± 51 | 983 ± 221** | 296 ± 16 | 857 ± 48*** | 313 ± 17 | 926 ± 53*** | AF035830 |
Period homolog 3 (Drosophila); Per3 | 75 ± 42 | 384 ± 51** | 224 ± 22 | 438 ± 24*** | 282 ± 11 | 409 ± 26 | NM_011067 |
D site albumin promoter binding protein; Dbp | 222 ± 63 | 613 ± 110** | 505 ± 58 | 530 ± 80# | 509 ± 44 | 446 ± 91 | BC018323 |
Cryptochrome 1; Cry1 | 143 ± 45 | 260 ± 91# | 61 ± 8 | 222 ± 25*** | 88 ± 6 | 281 ± 42** | BG069864 |
Hepatic leukemia factor; Hlf | 150 ± 52 | 425 ± 129# | 173 ± 25 | 383 ± 25*** | 188 ± 14 | 405 ± 76 | BB744589 |
DNA-damage-inducible transcript 4; Ddit4 | 983 ± 346 | 1,470 ± 434# | 637 ± 110 | 1,136 ± 122** | 967 ± 60 | 815 ± 92 | AK017926 |
Thyrotroph embryonic factor; Tef | 1,545 ± 282 | 3,447 ± 565** | 1,883 ± 124 | 3,151 ± 182*** | 2,138 ± 81 | 2,836 ± 233 | BC017689 |
v-maf musculoaponeurotic fibrosarcoma oncogene family F; Maff | 164 ± 31 | 453 ± 61** | 239 ± 35 | 421 ± 18*** | 214 ± 18 | 359 ± 29 | BC022952 |
FK506 binding protein 5; Fkbp5 | 136 ± 23 | 377 ± 78** | 169 ± 6 | 397 ± 26*** | 116 ± 19 | 327 ± 45** | U16959 |
Cold inducible RNA binding protein; Cirbp | 373 ± 68 | 502 ± 55# | 231 ± 35 | 551 ± 44*** | 629 ± 29 | 610 ± 113# | NM_007705 |
Epithelial stromal interaction 1 (breast); Epsti1 | 421 ± 83 | 274 ± 75# | 299 ± 15 | 149 ± 3*** | 424 ± 56 | 399 ± 18# | BF020640 |
SAM domain, SH3 domain & nuclear localisation signals 1; Samsn1 | 185 ± 56 | 104 ± 39# | 119 ± 4 | 53 ± 2*** | 106 ± 6 | 197 ± 45# | NM_023380 |
Neutrophil cytosolic factor 4; Ncf4 | 226 ± 54 | 125 ± 44# | 190 ± 30 | 77 ± 4** | 168 ± 14 | 362 ± 66* | NM_008677 |
Tripartite motif protein 30///tripartite motif protein 30-like; Trim30 | 646 ± 216 | 942 ± 598# | 398 ± 51 | 206 ± 22** | 376 ± 38 | 593 ± 64** | BG068242 |
Nuclear factor, erythroid derived 2; Nfe2 | 106 ± 18 | 71 ± 13# | 133 ± 14 | 78 ± 4** | 108 ± 5 | 325 ± 79* | L09600 |
POU domain, class 2, associating factor 1; Pou2af1 | 418 ± 10 | 201 ± 97# | 222 ± 38 | 112 ± 9** | 346 ± 21 | 266 ± 71# | NM_011136 |
Deafness, autosomal dominant 5 homolog (human); Dfna5 h | 47 ± 16 | 31 ± 6# | 43 ± 7 | 19 ± 4** | 28 ± 4 | 172 ± 45** | NM_018769 |
Zinc finger and BTB domain containing 16; Zbtb16 | 101 ± 24 | 152 ± 33# | 113 ± 20 | 129 ± 14# | 74 ± 1 | 162 ± 21** | Z47205 |
Erythroid differentiation regulator 1; Erdr1 | 712 ± 133 | 642 ± 121# | 525 ± 60 | 442 ± 157# | 366 ± 131 | 870 ± 107** | AJ007909 |
Nuclear receptor subfamily 1, d1; Nr1d1 | 415 ± 106 | 245 ± 29# | 406 ± 20 | 317 ± 33* | 504 ± 20 | 243 ± 40** | W13191 |
Neuronatin; Nnat | 205 ± 57 | 138 ± 13# | 132 ± 12 | 109 ± 7# | 198 ± 24 | 159 ± 16# | AV218841 |
Pleckstrin homology domain containing, a6; Plekha6 | 109 ± 21 | 98 ± 28# | 91 ± 10 | 72 ± 8# | 180 ± 9 | 99 ± 12** | BB486127 |
Unknown gene | |||||||
RIKEN cDNA 9030611N15 gene | 1,085 ± 293 | 2,188 ± 530# | 7,12.3 ± 90.3 | 2,028 ± 102*** | 788 ± 44 | 1,899 ± 155*** | NM_134072 |
Expressed sequence AI447904 | 885 ± 283 | 364 ± 137# | 421 ± 23.7 | 171 ± 13*** | 585 ± 53 | 515 ± 42# | BM241008 |
DNA segment, Chr 7, Wayne State University 130, expressed | 42.2 ± 12.6 | 124 ± 45# | 37 ± 10 | 95 ± 17** | 40 ± 4 | 94 ± 9** | AI480533 |
– | 289 ± 104 | 591 ± 176# | 252 ± 44 | 437 ± 59** | 364 ± 45 | 359 ± 56# | BC003855 |
– | 89 ± 37 | 162 ± 46# | 74 ± 13 | 113 ± 12* | 93 ± 25 | 118 ± 33# | M11024 |
RIKEN cDNA 1700012B18 gene | 138 ± 37 | 329 ± 81* | 112 ± 8 | 259 ± 18*** | 145 ± 24 | 374 ± 37** | BC022135 |
RIKEN cDNA C130076O07 gene | 231 ± 48 | 81 ± 16** | 184 ± 12 | 70 ± 6*** | 191 ± 18 | 97 ± 20** | BB202655 |
RIKEN cDNA 6330500D04 gene | 482 ± 140 | 239 ± 68# | 328 ± 47 | 149 ± 4** | 371 ± 34 | 610 ± 102# | BM242294 |
– | 518 ± 133 | 202 ± 48** | 228 ± 34 | 121 ± 8** | 368 ± 58 | 309 ± 27# | BE686052 |
RIKEN cDNA 1100001G20 gene | 208 ± 30 | 202 ± 50# | 311 ± 42 | 168 ± 16** | 153 ± 15 | 1,268 ± 394* | AV006463 |
RIKEN cDNA 2300003P22 gene | 61 ± 13 | 33 ± 7# | 139 ± 51 | 96 ± 60# | 33 ± 12 | 842 ± 278* | AK004007 |
CD300 antigen like family member F | 328 ± 93 | 186 ± 41# | 290 ± 78 | 162 ± 7# | 171 ± 7 | 699 ± 156** | BM230330 |